Can we predict who ketamine helps? new study seeks answers
NCT ID NCT05625555
First seen May 24, 2026 · Last updated May 24, 2026
Summary
This study aims to find clues that show which patients with treatment-resistant depression will respond best to a single dose of IV ketamine. Researchers will study 40 adults with depression or bipolar disorder who haven't improved with other treatments. Participants will receive both ketamine and a placebo at different times, and researchers will track symptoms and use interviews, questionnaires, and brain activity tests to identify predictors of rapid and lasting improvement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mood Disorders Program
Halifax, Nova Scotia, B3H2E2, Canada
Conditions
Explore the condition pages connected to this study.